There’s still little evidence of the big things that have long been expected for the JSE’s bombed-out small-cap counters so far in 2019. With the overall market — courtesy of an early resource sector rally and sprightlier performance from market heavyweights like Naspers, British American Tobacco, Richemont and AB InBev — looking firmer in the first quarter, there was a more than reasonable expectation from wide-eyed punters that small-cap counters might catch this swelling wave of improved sentiment. Not quite. Risk aversion still seems prevalent in 2019, which probably means further outflows from smaller-cap counters — perceived as higher risk — to the relative safety of recovering blue-chip counters. Some of the most popular small-cap counters have actually got cheaper — and, in some instances, a whole lot cheaper. There are more than a few notable mid-cap fizzles — including PSG-owned agribusiness Zeder, health-care group Ascendis (now a small cap by definition), Blue Label Tele...

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as exclusive Financial Times articles, ProfileData financial data, and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.

Questions or problems? Email or call 0860 52 52 00. Got a subscription voucher? Redeem it now